Buscar
Inmode Ltd
INMDAñadir a la lista de seguimiento
15.140USD
+0.045+0.30%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
870.26MCap. mercado
11.06P/E TTM
Más Datos de Inmode Ltd Compañía
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Información de Inmode Ltd
Símbolo de cotizaciónINMD
Nombre de la empresaInmode Ltd
Fecha de salida a bolsaAug 08, 2019
Director ejecutivoMizrahy (Moshe)
Número de empleados599
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
DirecciónTavor Building, Sha'ar Yokneam
CiudadYOKNEAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal2069200
Teléfono97249097470
Sitio Webhttps://inmodemd.com/
Símbolo de cotizaciónINMD
Fecha de salida a bolsaAug 08, 2019
Director ejecutivoMizrahy (Moshe)
Ejecutivos de Inmode Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Moshe Mizrahy
Mr. Moshe Mizrahy
Chief Executive Officer
Chief Executive Officer
4.30M
--
Dr. Michael Kreindel
Dr. Michael Kreindel
Chief Technology Officer, Director
Chief Technology Officer, Director
3.11M
--
Mr. Yair Malca
Mr. Yair Malca
Chief Financial Officer
Chief Financial Officer
71.14K
+29.37%
Dr. Hadar Ron, M.D.
Dr. Hadar Ron, M.D.
Independent Director
Independent Director
55.27K
-7.24%
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Miri Segal-Scharia
Ms. Miri Segal-Scharia
CEO - MS IR LLC
CEO - MS IR LLC
--
--
Mr. Nadav Kenneth
Mr. Nadav Kenneth
Independent Director
Independent Director
--
-100.00%
Mr. Brandon Nye
Mr. Brandon Nye
Vice President - Sales of West US
Vice President - Sales of West US
--
--
Mr. Michael Dennison
Mr. Michael Dennison
President, North America
President, North America
--
--
Mr. Matt Rodgers
Mr. Matt Rodgers
Vice President - Sales of Canada
Vice President - Sales of Canada
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Moshe Mizrahy
Mr. Moshe Mizrahy
Chief Executive Officer
Chief Executive Officer
4.30M
--
Dr. Michael Kreindel
Dr. Michael Kreindel
Chief Technology Officer, Director
Chief Technology Officer, Director
3.11M
--
Mr. Yair Malca
Mr. Yair Malca
Chief Financial Officer
Chief Financial Officer
71.14K
+29.37%
Dr. Hadar Ron, M.D.
Dr. Hadar Ron, M.D.
Independent Director
Independent Director
55.27K
-7.24%
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Miri Segal-Scharia
Ms. Miri Segal-Scharia
CEO - MS IR LLC
CEO - MS IR LLC
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Inmode Ltd?
Los cinco principales accionistas de Inmode Ltd son: Mr. Moshe Mizrahy
¿Cuántas instituciones poseen acciones de Inmode Ltd (INMD)?
A fecha de 2026Q1, 582 instituciones poseen acciones de Inmode Ltd, con un valor de mercado combinado de aproximadamente 33.96M, lo que representa el 53.60% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -18464721.00.